2)- Yongjun Qin, Rongmei Ma, Yang Li, Yifeng Li, Gong Chen, Weichang Zhou. Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture.Antibody therapeutics. 2022, 5 (2): 111-120
3)- Hussain Dahodwala, Sophia D Amenyah, Sarah Nicoletti, Matthew N Henry, Diane J Lees-Murdock, Susan T Sharfstein. Evaluation of site-specific methylation of the CMV promoter and its role in CHO cell productivity of a recombinant monoclonal antibody.Antibody therapeutics. 2022, 5 (2): 121-129
4)- Emily Engelhart, Randolph Lopez, Ryan Emerson, Charles Lin, Colleen Shikany, Daniel Guion, Mary Kelley, David Younger. Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants.Antibody therapeutics. 2022, 5 (2): 130-137
5)- Jianxin Huo, Yuhan Huang, Ziying Zheng, Xin Ni Tay, Farouq Bin Mahfut, Wei Zhang, Kong-Peng Lam, Yuansheng Yang, Shengli Xu. Development of a T cell-redirecting bispecific antibody targeting B-cell maturation antigen for the suppression of multiple myeloma cell growth.Antibody therapeutics. 2022, 5 (2): 138-149